1. Home
  2. PT vs CTXR Comparison

PT vs CTXR Comparison

Compare PT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • CTXR
  • Stock Information
  • Founded
  • PT 2012
  • CTXR 2007
  • Country
  • PT China
  • CTXR United States
  • Employees
  • PT N/A
  • CTXR N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • CTXR Health Care
  • Exchange
  • PT Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • PT 15.2M
  • CTXR 14.6M
  • IPO Year
  • PT 2018
  • CTXR N/A
  • Fundamental
  • Price
  • PT $0.90
  • CTXR $1.53
  • Analyst Decision
  • PT
  • CTXR Strong Buy
  • Analyst Count
  • PT 0
  • CTXR 3
  • Target Price
  • PT N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • PT 15.7K
  • CTXR 6.7M
  • Earning Date
  • PT 07-07-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • PT N/A
  • CTXR N/A
  • EPS Growth
  • PT N/A
  • CTXR N/A
  • EPS
  • PT N/A
  • CTXR N/A
  • Revenue
  • PT $4,814,566.00
  • CTXR N/A
  • Revenue This Year
  • PT N/A
  • CTXR N/A
  • Revenue Next Year
  • PT N/A
  • CTXR N/A
  • P/E Ratio
  • PT N/A
  • CTXR N/A
  • Revenue Growth
  • PT N/A
  • CTXR N/A
  • 52 Week Low
  • PT $0.76
  • CTXR $0.65
  • 52 Week High
  • PT $1.15
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • PT 46.18
  • CTXR 68.44
  • Support Level
  • PT $0.82
  • CTXR $0.76
  • Resistance Level
  • PT $0.94
  • CTXR $1.45
  • Average True Range (ATR)
  • PT 0.06
  • CTXR 0.31
  • MACD
  • PT 0.00
  • CTXR 0.06
  • Stochastic Oscillator
  • PT 57.14
  • CTXR 47.63

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: